7.90
+0.38%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Orthofix Medical
From its filings with the US Securities and Exchange Commission
Orthofix Medical is based in Lewisville, Texas. Its shares trade on Nasdaq under the ticker OFIX. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $822.3m and a net loss of $92.2m. At that date it held total assets of $850.6m and shareholders' equity of $450.0m. By business, Global Spine [Member] brought in 83.6% of revenue, followed by Global Limb Reconstruction [Member] at 16.4%.
Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, Orthofix delivers exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System.
The Company was founded in Verona, Italy in 1980 and formally incorporated in 1987 in Curaçao as "Orthofix International N.V." In 2018, we completed a change in our jurisdiction of organization from Curaçao to the State of Delaware and changed our name to "Orthofix Medical Inc." As a result, we are a corporation existing under the laws of the State of Delaware.
In January 2023, we completed a "merger of equals" transaction with SeaSpine Holdings Corporation ("SeaSpine") whereby we acquired SeaSpine via an all-stock merger (the "Merger"). As a result of the Merger, each share of SeaSpine common stock issued and outstanding immediately prior to the closing of the Merger was converted into 0.4163 shares of Orthofix common stock. Following the Merger, the shares of common stock of Orthofix, as the corporate parent entity in the combined company structure, continued to trade on NASDAQ under the symbol "OFIX".
Quoted from its 10-K, filed 24 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 24 Apr 1992
- Employees
- 1,605
- Head office
- 3451 PLANO PARKWAY, LEWISVILLE, TX, 75056
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Accelerated filer
Leadership
Pay as last reported
- Mr. Michael FineganIndependent Chairman of the Board, since 2006$472,320
- Mr. Massimo CalafiorePresident, Chief Executive Officer, Director, since 2024$10.6m
- Ms. Julie AndrewsChief Financial Officer$3.2m
- Mr. Patrick FisherPresident - Global Orthopedics
- Mr. Max ReinhardtPresident - Global Spine$2.8m
- Mr. Lucas VitaleChief People and Business Operations Officer$4.1m
- Mr. Geoffrey GillespieChief Accounting Officer$917,932
- Ms. Julie DeweyChief Investor Relations and Communications Officer
- Mr. J. Andres CedronChief Legal Officer$2.4m
- Mr. Alan BazaarIndependent Director$379,453
- Mr. Wayne BurrisIndependent Director$274,289
- Ms. Vickie CappsIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 38
- Environment
- 30
- Social
- 33
- Governance
- 52
- Direct emissions (scope 1)
- 669 t
- Energy emissions (scope 2)
- 2,619 t
- Women in the workforce
- 49%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Orthofix Medical Inc. has several strengths that contribute to its competitive advantage in the market.
Weaknesses
- Despite its strengths, Orthofix Medical Inc. also faces certain weaknesses that may hinder its growth and performance.
Opportunities
- Orthofix Medical Inc. can capitalize on various opportunities to further expand its presence and improve its market position.
Threats
- Orthofix Medical Inc. should be mindful of potential threats that may impact its operations and market position.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.